These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22402308)

  • 21. PPARgamma polymorphisms and cancer risk: a meta-analysis involving 32,138 subjects.
    Xu W; Li Y; Wang X; Chen B; Liu S; Wang Y; Zhao W; Wu J
    Oncol Rep; 2010 Aug; 24(2):579-85. PubMed ID: 20596649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Cox-2 -1195 G > A polymorphism and cancer risk: a meta-analysis of 25 case-control studies.
    Tang Z; Nie ZL; Pan Y; Zhang L; Gao L; Zhang Q; Qu L; He B; Song G; Zhang Y; Shukui Wang
    Mutagenesis; 2011 Nov; 26(6):729-34. PubMed ID: 21734230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis.
    Xi B; Zeng T; Liu L; Liang Y; Liu W; Hu Y; Li J
    Breast Cancer Res Treat; 2011 Nov; 130(2):561-8. PubMed ID: 21638051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.
    Zhang Z; Xue H; Gong W; Wang M; Yuan L; Han S; Zhang Z
    Carcinogenesis; 2009 Mar; 30(3):487-93. PubMed ID: 19168581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis.
    Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H
    Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.
    Peng B; Cao L; Ma X; Wang W; Wang D; Yu L
    Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphisms in the tobacco smoke carcinogens detoxifying enzyme UGT1A7 and the risk of head and neck cancer.
    Lacko M; Roelofs HM; te Morsche RH; Voogd AC; Ophuis MB; Peters WH; Manni JJ
    Head Neck; 2009 Oct; 31(10):1274-81. PubMed ID: 19360737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between IGF1 CA repeat polymorphisms and breast cancer risk: a meta-analysis.
    Huang Q; Wang C; Qiu LJ; Shao F; Yu JH
    Breast Cancer Res Treat; 2011 Aug; 129(1):191-4. PubMed ID: 21390492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between common genetic variant of microRNA-146a and cancer susceptibility.
    Qiu LX; He J; Wang MY; Zhang RX; Shi TY; Zhu ML; Mao C; Sun S; Lv FF; Zheng CL; Zhu XD
    Cytokine; 2011 Dec; 56(3):695-8. PubMed ID: 21978540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: evidence from 83 case-control studies.
    Wang W; Wang M; Chen Y; Zhang Z; Wang S; Xu M; Wang B; Zhao Q; Zhang Z
    Mutagenesis; 2012 May; 27(3):329-36. PubMed ID: 22121210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.
    Qiu LX; Yao L; Zhang J; Zhu XD; Zhao XM; Xue K; Mao C; Chen B; Zhan P; Yuan H; Hu XC
    Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms of the UDP-glucuronosyltransferase 1A7 gene and irinotecan toxicity in Japanese cancer patients.
    Ando M; Ando Y; Sekido Y; Ando M; Shimokata K; Hasegawa Y
    Jpn J Cancer Res; 2002 May; 93(5):591-7. PubMed ID: 12036456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STK15 rs2273535 polymorphism and cancer risk: a meta-analysis of 74,896 subjects.
    Xu L; Zhou X; Jiang F; Xu L; Yin R
    Cancer Epidemiol; 2014 Apr; 38(2):111-7. PubMed ID: 24252226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk.
    Zheng Z; Park JY; Guillemette C; Schantz SP; Lazarus P
    J Natl Cancer Inst; 2001 Sep; 93(18):1411-8. PubMed ID: 11562393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between TA-repeat polymorphism in the promoter region of UGT1A1 and breast cancer risk: a meta-analysis.
    Yao L; Qiu LX; Yu L; Yang Z; Yu XJ; Zhong Y; Yu L
    Breast Cancer Res Treat; 2010 Aug; 122(3):879-82. PubMed ID: 20087647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation of polymorphisms of UDP-glucuronosyltransferase 1A7 gene to genetic susceptibility of lung cancer].
    Feng FY; Liang G; Lu WF; Miao XP; Yu CY; Tan W; Zhou YF; Sun T; Kang B; Zhou T; Pan KF; Zhang L; Lin DX
    Ai Zheng; 2005 Sep; 24(9):1085-90. PubMed ID: 16159430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene.
    Vogel A; Kneip S; Barut A; Ehmer U; Tukey RH; Manns MP; Strassburg CP
    Gastroenterology; 2001 Nov; 121(5):1136-44. PubMed ID: 11677206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms in human UDP-glucuronosyltransferases 1A7 and the risk of gastrointestinal carcinomas: A systematic review and network meta-analysis.
    Zhang Y; Hou J; Feng F; Li D; Jiang Q; Li X; Zhao Q; Li BA
    Oncotarget; 2017 Sep; 8(39):66371-66381. PubMed ID: 29029519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor 2 gene polymorphisms and cancer susceptibility: a meta-analysis.
    Wang X; Li J; Xie W; Zhang W; Chang Y
    Neoplasma; 2013; 60(4):459-67. PubMed ID: 23581420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
    Zhang F; Yang Y; Guo C; Wang Y
    Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.